Lassie doesn't compete with a Workday or a Salesforce. The incumbent in dental billing is the human administrator who just quit. That absence of a tech incumbent is exactly what makes the market so compelling and the product so defensible.
Lassie doesn't compete with a Workday or a Salesforce. The incumbent in dental billing is the human administrator who just quit. That absence of a tech incumbent is exactly what makes the market so compelling and the product so defensible.
Where this was said
At 43:00 · chapter starts 36:25
Alex Rampell has built a career on one observation: startups win when they capture distribution before incumbents copy the innovation. He traces this through the TiVo story — a genuine innovation that built no durable moat because every cable company had both the incentive and the ability to replicate it — and through his own TrialPay experience, where he realized he should have been building Stripe instead. The AI era complicates this framework in two ways simultaneously: AI makes it easier for incumbents to copy innovations (a bad engineer with AI tools is now a decent engineer), but it also creates vast categories where there was never a software incumbent at all. Dental billing is the canonical example [1] — Alex Rampell "Who is the giant-ass incumbent of dental software? There isn't an incumbent. The incumbent was named Betty and she quit 2 weeks ago." 45:20 . There is no Workday for dental practices. There is no Salesforce for Dr. Sloop's claims processing. The 'incumbent' is a person — Betty, the billing assistant, who quit two weeks ago and now works at the coffee shop. When your competitor is human labor rather than entrenched software, the dynamics change entirely: no one is going to match your innovation before you lock in distribution, because no one was building software in the first place. Steijn Pelle extends the argument: the schlep of building proper integrations, ontologies, and agent systems creates years of defensibility that Betty's replacement simply cannot replicate.
Every startup-versus-incumbent battle reduces to one question: can the startup lock in distribution before the incumbent copies the innovation? In dental billing, there is no tech incumbent to race against. The category was served entirely by human labor — and that changes the calculus entirely.
Alex Rampell's core thesis: a startup wins if it captures distribution before the incumbent can replicate its innovation.
SiteGPT attracted over 1 million visitors and $500K in total revenue without spending a cent on paid marketing. The secret: engineering as marketing — building free tools that rank on Google.
Bhanu quit his first job after just 8 months, moved back to his parents' house to cut costs, and started building. One product sold for $250K; the next hit $10K MRR in its first month.
90% of SiteGPT's Google search traffic comes not from the main product but from ~50 free tools Bhanu built. Each tool targets a low-competition keyword and funnels users back to the paid product.
50,000 monthly visitors become 200 leads, 60 trials, and roughly 15–24 new customers per month at ~$100 average revenue each. Add a $1,700–$1,800 LTV and you have a very healthy SaaS.
Start with a blank Ahrefs search, layer in keyword filters (include term, KD < 10, volume > 1,000), list candidates in Notion, design a CTA linking to your main product, then score by volume, difficulty, build effort, and product relevance. That's the whole playbook.
Marketing feels painful for most builders. Engineering as marketing flips the script: instead of writing cold emails or blog posts, you build things — and those things rank on Google forever.
Don't spend months perfecting before launch. Ship the core feature, get real users, and let their feedback dictate the product roadmap. Premature polish is a trap.
SiteGPT launched and hit $10,000 MRR within its first month. That momentum was so overwhelming that Bhanu sold his existing SaaS, Feather, for $250,000 to free up all his time.
PropGPT launched with 20 downloads a day and strong influencer marketing but hit a ceiling at $1,000–$2,000 MRR. High download numbers masked a critical flaw: almost nobody stuck around after the free trial ended.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.